LY377604 + Sibutramine Hydrochloride Monohydrate: A Phase 2 Weight Loss Efficacy Study in Overweight/Obese Men and Women.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs LY 377604 (Primary) ; Metoprolol; Sibutramine
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 02 Jun 2011 Planned end date changed from 1 Jul 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 04 Jun 2010 Actual patient number (343) added as reported by ClinicalTrials.gov.
- 04 Jun 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.